Pertuzumab FDA approval date

The FDA approved Pertuzumab (Perjeta®) on 8 Jun 2012.

FDA approval date
8 Jun 2012

Drug identity checked against registry records

Also recorded as Perjeta®

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2012-06-08DayPertuzumabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125409", "applicant_as_listed_by_fda": "GENENTECH", "brand_names": ["PERJETA"], "active_ingredients": ["PERTUZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20120608", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026